Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/14/25 16:24 | 1/13/25 | AVDL | Health | Drug | Pharmaceutical Preparations | Thornton Peter J. | L2 | D | 1 | P | 80 | 8.05 | 0 | 10 | 11 | 104 | D | |||||||||||||||
1/14/25 16:22 | 1/13/25 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | 1 | P | 235 | 7.84 | 0 | 30 | 17 | 209 | D | |||||||||||||||
12/16/24 07:00 | 12/13/24 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | 3 | P | 105 | 11.34 | 0 | 9 | 12 | 88 | D | ||||||||||||||
12/10/24 18:14 | 12/6/24 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Gregory J | L2 | DO | CEO | 1 | P.m | 100 | 9.97 | 0 | 10 | 6 | 169 | I | ||||||||||||||
12/10/24 18:13 | 12/10/24 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | 1 | P | 200 | 9.84 | 0 | 20 | 30 | 87 | I | |||||||||||||||
12/10/24 07:00 | 12/6/24 | AVDL | Health | Drug | Pharmaceutical Preparations | Palczuk Linda | L2 | D | 1 | P | 31 | 10.19 | 0 | 3 | 5 | 66 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |